衰弱评分量表在老年创伤患者结局中的预测价值研究

注册号:

Registration number:

ChiCTR2600125456 

最近更新日期:

Date of Last Refreshed on:

2026-05-27 10:59:31 

注册时间:

Date of Registration:

2026-05-27 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

衰弱评分量表在老年创伤患者结局中的预测价值研究

Public title:

Study on the predictive value of the frailty score in the outcomes of elderly trauma patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

衰弱评分量表在老年创伤患者结局中的预测价值研究

Scientific title:

Study on the predictive value of the frailty score in the outcomes of elderly trauma patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

马小丽 

研究负责人:

马小丽 

Applicant:

Ma Xiaoli 

Study leader:

Ma Xiaoli 

申请注册联系人电话:

Applicant telephone:

+86 150 8687 0672

研究负责人电话:

Study leader's
telephone:

+86 150 8687 0672

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

562015503@qq.com

研究负责人电子邮件:

Study leader's E-mail:

562015503@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国重庆市合川区南津街道希尔安大道1366号

研究负责人通讯地址:

中国重庆市合川区南津街道希尔安大道1366号

Applicant address:

1366 Xi'er'an Avenue, Nanjin Subdistrict, Hechuan District, Chongqing, China

Study leader's address:

1366 Xi'er'an Avenue, Nanjin Subdistrict, Hechuan District, Chongqing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

重庆市合川区人民医院

Applicant's institution:

The People's Hospital of Chongqing Hechuan

研究负责人所在单位:

重庆市合川区人民医院

Affiliation of the Leader:

The People's Hospital of Chongqing Hechuan

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

YNJJ-2026-017-001

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

重庆市合川区人民医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of the People's Hospital of Chongqing Hechuan

伦理委员会批准日期:

Date of approved by ethic committee:

2026-02-09 00:00:00

伦理委员会联系人:

何婷婷

Contact Name of the ethic committee:

He Tingting

伦理委员会联系地址:

中国重庆市合川区南津街道希尔安大道1366号

Contact Address of the ethic committee:

1366 Xi'er'an Avenue, Nanjin Subdistrict, Hechuan District, Chongqing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 150 8687 0672

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

重庆市合川区人民医院

Primary sponsor:

The People's Hospital of Chongqing Hechuan

研究实施负责(组长)单位地址:

中国重庆市合川区南津街道希尔安大道1366号

Primary sponsor's address:

1366 Xi'er'an Avenue, Nanjin Subdistrict, Hechuan District, Chongqing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

合川

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆市合川区人民医院

具体地址:

中国重庆市合川区南津街道希尔安大道1366号

Institution
hospital:

The People's Hospital of Chongqing Hechuan

Address:

1366 Xi'er'an Avenue, Nanjin Subdistrict, Hechuan District, Chongqing, China

经费或物资来源:

院内科研基金

Source(s) of funding:

In-hospital research fund

研究疾病:

老年创伤  

Target disease:

Elderly trauma

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

老年创伤患者预后异质性大,传统损伤评分体系无法反映其生理储备。临床衰弱评分作为一种快速床旁评估工具,能有效量化老年人的生理脆弱性。本研究旨在系统性评估 CFS 在急诊创伤环境中的预警价值,推动诊疗模式从“以损伤为中心”向“以患者为中心” 转变,为早期风险分层与个体化干预提供关键证据。  

Objectives of Study:

The prognosis of elderly trauma patients is highly heterogeneous, and traditional injury scoring systems fail to reflect their physiological reserve. The Clinical Frailty Scale (CFS as a rapid bedside assessment tool, can effectively quantify the physiological vulnerability of the elderly. This study aims to systematically evaluate the early warning value of the CFS in the emergency trauma setting, a shift in the diagnosis and treatment model from "injury-centered" to "patient-centered," and providing key evidence for early risk stratification and individualized intervention.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1. 严重认知障碍或无法沟通; 2. 创伤后立即死亡或需紧急抢救无法完成评估; 3. 因烧伤、中毒等非机械性损伤入院; 4. 单纯性轻微伤(如无需缝合的皮肤裂伤、浅表擦伤)无需住院。

Exclusion criteria:

1. Severe cognitive impairment or inability to communicate; 2. Immediate death after trauma or inability to complete assessment due to the need for emergency resuscitation; 3. Admission due to non-mechanical injuries such as burns or poisoning; 4. Simple minor injuries (such as skin lacerations not requiring sutures, superficial abrasions) that do not require hospitalization.

研究实施时间:

Study execute time:

From 2026-06-01 00:00:00 To 2029-02-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-06-01 00:00:00 To 2026-12-31 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

2400

Group:

Observational group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆市合川区人民医院 

单位级别:

三甲 

Institution
hospital:

The People's Hospital of Chongqing Hechuan

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

衰弱评估

指标类型:

主要指标

Outcome:

Frailty Assessment

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

非计划转入ICU

指标类型:

主要指标

Outcome:

Unplanned Admission to ICU

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

总住院时长

指标类型:

次要指标

Outcome:

Total Hospital Length of Stay

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

ICU入住时长

指标类型:

次要指标

Outcome:

ICU Length of Stay

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

住院期间并发症发生率

指标类型:

次要指标

Outcome:

Incidence of Complications During Hospitalization

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

住院全因死亡率

指标类型:

次要指标

Outcome:

All-Cause Mortality During Hospitalization

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NO

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 65 years
最大 Max age NA years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

研究结束后半年;国家生物信息中心(https://www.cncb.ac.cn/)

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Six months after the completion of the research; China National Center for Bioinformation (https://www.cncb.ac.cn/)

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集:接诊护士、接诊医生在患者入科 24 小时内通过询问患者本人、家属及查阅病历的方式完成 CFS 评分。 数据管理:从医院电子病历系统提取。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection: Triage nurses and triage doctors complete the CFS score within 24 hours of the patient's admission by interviewing the patient and their family members and reviewing medical records. Data management: extracted from hospital electronic medical record systems.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-05-27 10:59:25